Abstract:Objective To explore the expression of Notch transduction signaling pathway in lung cancer stem cells and the effect on the cellular growth in vitro after blocking Notch signaling pathway.Methods Lung cancer stem cells and general tumor cells were isolated from human lung adenocarcinoma cell line A549 by the high speed sorting of flow cytometry based on surface marker of CD133.Expression of Notch transduction signaling pathway in lung cancer stem cells and general tumor cells were detected by real-time fluorescent quantitative polymerase chain reaction (FQ-PCR) and Western blotting.The proliferation of lung cancer stem cells and general tumor cells in vitro was detected by cell counting kit-8 (CCK-8) respectively,and the growth curves of lung cancer stem cells and general tumor cells were described and compared.After blocking the Notch transduction signaling pathway by γ-secretase Inhibitor (DAPT),a γ-secretase inhibitor,cellular growth in lung cancer stem cells and general tumor cells was both observed and analyzed.Results CD133 positive cells (served as lung cancer stem cell) occupied (0.40 ± 0.11) ％ of all A549 cells before the high speed sorting by flow cytometry,while the percentage of CD133 positive cells reached to (95.00 ± 0.63)％ after the high speed sorting of flow cytometry,with significant difference (P ＜ 0.01).Homogeneity of lung cancer stem cells could be achieved based on the high speed sorting of flow cytometry.Expressions of Notch transduction signaling pathway were observed in both cancer stem cells and general tumor cells,however significantly lower expression was found in lung cancer stem cells (compared to general tumor cells of lung adenocarcinoma cells,P ＜ 0.05).The growth curves showed that the proliferate potential of lung cancer stem cells in vitro was similar to the proliferation of lung general tumor cells,with no significant difference (P ＞ 0.05).However,after 48 h of DAPT intervention,variant inhibitions of growth were shown.Compared to general tumor cells[(21.5 ±3.4)％],growth inhibitory rate of cancer stem cells [(33.7 ± 1.9) ％] increased obviously,indicating a statistically significant difference (P ＜ 0.05).Conclusion Conclusion Inhibitory effect on the growth of lung cancer stem cells was more significant.It may be related to overexpression of Notch inhibited by DAPT and its negative feedback effect on lung cancer cells.

Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.

Wnt/β-catenin signaling regulates cancer stem cells in lung cancer A549 cells

Wnt/β-catenin Signaling Pathway in Lung Cancer Stem Cells is a Potential Target for the Development of Novel Anticancer Drugs.

Constitutive Expression Of Wnt/Beta-Catenin Target Genes Promotes Proliferation And Invasion Of Liver Cancer Stem Cells

Wnt Signaling Regulates the Stemness of Lung Cancer Stem Cells and Its Inhibitors Exert Anticancer Effect on Lung Cancer SPC-A1 Cells

Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines

Acquisition of Epithelial–mesenchymal Transition Phenotype and Cancer Stem Cell-Like Properties in Cisplatin-Resistant Lung Cancer Cells Through AKT/β-catenin/Snail Signaling Pathway

CCAT1 Stimulation of the Symmetric Division of NSCLC Stem Cells Through Activation of the Wnt Signalling Cascade

Inhibition of Wnt/β-catenin Pathway Reverses Multi-Drug Resistance and EMT in Oct4+/Nanog+ NSCLC Cells.

Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway

Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway

Expression of Notch signaling transduction pathway in lung cancer stem cells

Targeting the Wnt-Regulatory Protein CTNNBIP1 by Microrna-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas.

Blocking the Notch Pathway Can Inhibit the Growth of Cd133-Positive A549 Cells and Sensitize to Chemotherapy

Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in Cd133(+) Lung Carcinoma A549 Cells

An SETD1A/Wnt/β-catenin feedback loop promotes NSCLC development

Aberrantly Expressed Mir-582-3p Maintains Lung Cancer Stem Cell-Like Traits by Activating Wnt/β-catenin Signalling

Wnt3 Knockdown Sensitizes Human Non-Small Cell Type Lung Cancer (NSCLC) Cells to Cisplatin Via Regulating the Cell Proliferation and Apoptosis

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies

Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.